The susceptibilities of 350 gram-positive cocci and 638 gram-negative bacilli to various antimicrobial agents were compared by using the Micro-Media system (MMS) (Fox Panel) (Micro-Media Systems, Inc., Potomac, Md.) and a standard agar dilution procedure. Major discrepancies occurred with enterococci, among which 48 of 53 isolates (91%) were found to be resistant to penicillin G by agar dilution and reported as susceptible by the MMS. Other large discrepancies occurred with Staphylococcus aureus and Acinetobacter calcoaceticus subsp. anitratus, among which more than 40% of the isolates were judged to be resistant to ampicillin by agar dilution and susceptible by the MMS. In terms of overall agreement in interpretation of MICs by the two systems, an agreement of greater than 84% was seen for both gram-positive and gram-negative organisms when ampicillin and cephalothin (68 and 78% agreement for gram-positive cocci, respectively) were excluded. published procedure (10). Horse blood (5%) was added to Mueller-Hinton agar plates containing trimethoprimsulfamethoxazole for optimal endpoint reading (3, 6). The plates were incubated at 35°C for 18 h and examined for growth. The MIC was defined as the lowest concentration of antimicrobial agent at which the isolate failed to grow.
The quantitative susceptibility testing of bacteria by a commerically available broth microdilution technique (Micro-Media system [MMS] ) (Micro-Media Systems, Inc., Potomac, Md.) has been favorably compared with the macrobroth dilution method as well as the agar dilution and diffusion procedures (1, 19) . Since the time of these evaluations, several modifications of the MMS have been made. These changes include a reduced assay volume from 0.1 to 0.04 ml, with concomitantly fewer organisms per well; new antimicrobial agents; and a broth medium that is supplemented with 5 ,ug of calcium and 25 ,ug of magnesium per ml. The purpose of the present report was to compare the susceptibilities of 988 aerobic gram-negative and grampositive clinical isolates to various antimicrobial agents as determined by the modified MMS (Fox Panel) and by a standard agar dilution method.
MATERIALS AND METHODS
Bacterial isolates. A total of 988 clinical isolates were obtained from the clinical microbiology laboratory of Parkland Memorial Hospital, Dallas, Tex. These isolates included 350 aerobic gram-positive cocci and 638 gram-negative bacilli. The isolates were identified by standard procedures (9, 11, 13, 15) . Susceptibility testing. Commercially available MMS trays were obtained from the manufacturer. Susceptibility tests were performed by the instructions of the manufacturer. For the agar dilution method, the bacterial isolates were grown overnight on blood agar, inoculated into Mueller-Hinton broth, and incubated for 5 to (23) .
RESULTS
The two methods were compared by their respective "susceptible" or "resistant" MIC interpretations because (i) the interpretation of the MICs for the MMS and the agar dilution method are frequently different by several dilutions (according to the manufacturer) (23) , and (ii) some antimicrobial agents in the MMS are provided at only one concentration (e.g., cefamandole, ticarcillin, and trimethoprimsulfamethoxazole). Tables 1 and 2 show the major discrepancies (when greater than 15% of the isolates tested had different MIC interpretations and the MICs in the two systems were a minimum of two dilutions different from each other, when comparison was possible) between the agar dilution method and the MMS for gram-positive cocci (Table  1 ) and gram-negative bacilli ( Table 2) .
The interpretative MIC criteria used in the MMS were "very susceptible" and "resistant," and those used in the agar dilution method were "susceptible" and "resistant." Shigella spp. method. These authors found overall agreement among the three methods to be 88.7 to 92.7% (19) . The MMS (Fox Panel) used in the present study differs significantly from that evaluated by Peterson et al. (19) in that it contains fewer organisms per well (4,000 CFU, in contrast to 10,000 CFU with the old MMS panel), additional antimicrobial agents, and a broth medium in the wells that is supplemented with calcium and magnesium. The most significant discrepancy between the two systems occurred with penicillin G against enterococci, of which 48 of 53 (91%) clinical isolates were resistant by agar dilution (MIC, >4 p.g/ml) and susceptible by the MMS (MIC, <16 ,lg/ml). Forty-five percent of these enterococcal isolates had penicillin G MICs of 0.5 to 2 ,ug/ml in the MMS and were classified as "moderately susceptible (MIC, 0.5 to 16 ,ug/ml)" according to the instructions of the manufacturer.
The resistance of enterococci to penicillin G is well documented (12, 15, 17, 18, 21, 24) , as is the high failure rate observed when penicillin alone is used for the treatment of enterococcal endocarditis (12) . Another large discrepancy observed among gram-positive cocci occurred with Staphylococcus aureus isolates. Of 261 isolates, 103 (40%) were reported as susceptible to ampicillin by the MMS and resistant by the agar dilution method. Ampicillin is susceptible to penicillin ,-lactamase (25) , which has been shown to be present in 90% of 1,982 isolates of Staphylococcus aureus collected over a 4-year period (2) . The agar dilution result therefore appears to be more representative of actual ampicillin susceptibility.
Although microbroth dilution MICs have been shown, on the average, to be severalfold lower than agar dilution MICs (e.g., with ampicillin against enterococci) (8), the results reported here compare the interpretation of the MICs as related to susceptible or resistant categories according to established criteria. Thus, a comparison can be made between two methods which have different MIC standards for susceptible and resistant groupings and in which different drug concentrations are used.
Of 42 isolates of A. calcoaceticus subsp. anitratus, 32 (78%) were found to be resistant to ampicillin by agar dilution and susceptible by the MMS. Greater than 70% of 62 clinical isolates of A. calcoaceticus subsp. anitratus have been reported by others to be resistant to ampicillin (18, 26) . On the basis of these studies and our agar dilution results, the use of ampicillin to treat infections caused by A. calcoaceticus subsp. anitratus seems questionable.
Of the new antimicrobial agents added to the MMS, only moxalactam showed major disagreements between the two systems when tested with A. calcoaceticus subsp. anitratus and P. aeruginosa. Another major disagreement between the MMS and the agar dilution method was seen with P. aeruginosa when tested with gentamicin. Of 152 of the isolates, 29 (19%) were found to be susceptible by agar dilution and resistant by the MMS. This is in contrast to the work of Peterson et al. (19) , who found that P. aeruginosa may appear more susceptible in the MMS than in the agar dilution method when tested with aminoglycosides, including gentamicin. One possible explanation for this discrepancy may be that, in the old MMS panel used by Peterson et al. (19) , there was no supplementation with calcium or magnesium. In an accompanying report, Cherne and Peterson (4) found that, when a cation-supplemented inoculum was used with the MMS, there was a much greater agreement in MICs between the agar dilution method and the MMS for aminoglycoside susceptibility testing of P. aeruginosa. In a study of 1,065 clinical isolates of P. aeruginosa, 84% were found to be susceptible to gentamicin at .2 ,ug/ml and 93% at 4 ,ug/ml (7) . Although the frequency of resistance of P. aeruginosa to gentamicin may vary from hospital to hospital, the use of gentamicin for chemotherapy of such infections appears to be useful (14) .
Another major disagreement between the two methods occurred with Serratia marcescens. We found that 11 of 29 isolates were resistant to tobramycin and chloramphenicol by agar dilution and all but 2 of a total of 38 isolates tested were found to be susceptible when tested in the MMS. In a report by Edson and Keys (7), 69% (255 of 370) of clinical isolates of S. marcescens were susceptible to tobramycin, as compared with our agar dilution result of 69.4% (11 of 36) of isolates susceptible. In contrast, these authors (7) found that 94% (348 of 370) of the S. marcescens isolates were susceptible to gentamicin. The results of the present and previous studies, combined with those of an additional report documenting a greater activity of gentamicin over tobramycin (27) , suggest more clinical applicability of gentamicin for appropriate Serratia marcescens infections. Although chloramphenicol was also found to be in major disagreement between the two systems against Serratia marcescens, this drug is usually used only in combination with gentamicin for treatment of endocarditis caused by Serratia marcescens, for which it has been shown to be effective in some cases (16) .
The discrepancies seen here between the MMS and the agar dilution method may also be due to the relatively small number of CFU per well in the MMS (4,000 CFU), as compared with that (10,000 CFU per inoculation spot) (8) in the agar dilution system. This small inoculum (4,000 CFU) may not, therefore, be representative of the organisms tested. The inability to detect resistance with new antimicrobial susceptibility tests in which low numbers of CFU are used per test has recently been acknowledged to constitute a major problem in susceptibility testing, especially with staphylococci, enterococci, Serratia spp., and P. aeruginosa (20) . All of these organisms were shown in the present study to have major disagreements between the MMS and the agar dilution method, most often resulting in a resistant interpretation by the agar dilution method and a susceptible interpretation by the MMS. These and other discrepant results between the two systems may also be partly explained by differences in pH, bacterial growth rates in broth versus agar medium, and the inability to detect heterogenous bacterial strains (e.g., small-colony variants) in the MMS. Another factor may be the role of specific media components in the induction of ,-lactamases. It has recently been shown that VOL. 22, 1985 389 on July 2, 2017 by guest http://jcm.asm.org/ Downloaded from tryptophane, thiamine, and folic acid, in addition to Plactams, are potent inducers of P-lactamases (5) . Thus, some of the disagreements reported here between the MMS and the agar dilution method with 1-lactam agents and Morganella morganii, P. aeruginosa, E. coli, and Citrobacter diversus may be accounted for by certain medium constituents present in one or more concentrations in the two methods. As suggested by Sanders (20) , the monitoring of such problem organisms by an additional procedure, such as agar dilution or agar diffusion, may be necessary for accurate susceptibility reporting.
